The Value of Transurethral Electrolysis of the Prostate in Intermediate and Advanced Prostate Cancer
Objective To explore the value of transurethral resection of prostate for advanced prostate cancer.Meth-ods Clinical data of 68 patients with advanced prostate cancer admitted to Jiaozhou Hospital,East Hospital Affiliated to Tongji University from June 2022 to June 2023 were retrospectively selected and divided into analysis group and control group according to different treatment methods,with 34 cases in each group.The control group received con-ventional endocrine therapy,and the analysis group received transurethral resection of prostate based on the control group.The 5-year survival rate,maximum urine flow rate,residual urine volume,prostate-specific antigen,and Inter-national Prostate Symptom Score(IPSS)of the two groups were compared.Results There was no significant difference in 5-year survival rate between the two groups(P>0.05).The maximum urine flow rate,residual urine volume and prostate-specific antigen in the analysis group were significantly better than those in the control group,the difference were statistically significant(all P<0.05).The IPSS score of the analysis group was 2.61±1.20,lower than 5.36±1.49 of the control group,and the difference was statistically significant(t=8.382,P<0.05).Conclusion Transurethral resec-tion of prostate can effectively improve the symptoms of dysuria in patients with advanced prostate cancer without af-fecting the 5-year survival rate,which is worthy of clinical reference.
intermediate to advanced prostate cancertransurethral electrolysis of the prostateresults
NETL
NSTL
万方数据
